MARKETING ANALYSIS OF THE UKRAINIAN PHARMACEUTICAL MARKET OF ANTI-ECZEMA DRUGS
DOI:
https://doi.org/10.11603/2312-0967.2024.2.14744Keywords:
pharmaceutical market, eczema, drugs, medicinal preparations, soft dosage formsAbstract
The aim of the work. To carry out a marketing research of the drug assortment for the treatment of eczema, which are presented on the Ukrainian pharmaceutical market, with the aim of conducting further research on the creation and development of new drugs for eczema.
Materials and Methods. The work was carried out using official sources of information, in particular the information and search system of the "State Register of Medicinal Products of Ukraine", which was formed by the state body "State Expert Center of the Ministry of Health of Ukraine". System overview, statistical, structural, logical and graphic methods of analysis were used in the study.
Results and Discussion. The pharmaceutical market of Ukraine is characterized by a wide range of medicines used to treat eczema. The analysis of the assortment established that 158 drugs are represented, of which 72 are domestic drugs and 86 are imported drugs. Mainly, the Ukrainian pharmaceutical market presents means of imported production. These dermatological agents, used for the treatment of eczema, are drugs of five groups according to the ATS classification: D02 "Drugs with mitigating and protective action", D04 "Antipruritic drugs (including antihistamines, local anesthetics and other agents)", D06 "Antibiotics and chemotherapeutic drugs for use in dermatology", D07 "Corticosteroids for use in dermatology", D08 "Antiseptic and disinfectants". The drugs range is diverse in dosage forms, ointments and creams are the most common. Among the active substances of the studied drugs, the vast majority, namely 44, are synthetic: fluocinolone acetonide, methylprednisolone aceponate, clobetasol propionate, dexapantenol, desloratadine, fluticasone propionate, dimethindene maleate, diphenhydramine hydrochloride and others. Monopreparations predominate among the drugs of the studied group.
Conclusions. As a result of the conducted marketing research of the drugs range on the Ukrainian pharmaceutical market, which are used for the eczema treatment, we found that the development of new drugs in soft dosage forms is relevant.
References
Ayzyatulov RF, Polyakh YaO. [Features of the clinic and principles of treatment of eczema in the elderly and senile]. Zhurnal dermatovenerolohiyi ta kosmetolohiyi imeni M.O.Torsuyeva. 2020;43(1): 35–40. Ukrainian.
Buyanova IO. [Relevance of hepatoprotective therapy in patients with eczema]. Art of Medicine. 2018;5(1): 38–43. Ukrainian.
Sohn A et al. Eczema. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine. 2011;78(5): 730–739. DOI: 10.1002/msj.20289. DOI: https://doi.org/10.1002/msj.20289
Diepgen TL et al. Management of chronic hand eczema. Contact Dermatitis. 2007;57(4): 203–210. DOI: 10.1111/j.1600-0536.2007.01179.x. DOI: https://doi.org/10.1111/j.1600-0536.2007.01179.x
Fedotov VP, Dyudyun AD, Stepanenko VI. [Dermatovenerology: Education. a guide for doctors]. Dnipropetrovsʹk–Kyyiv : PP Svydler. 2008: 600. Ukrainian.
Hanifin JM, Reed ML. A Population-Based Survey of Eczema Prevalence in the United States. Dermatitis. 2007;18(2): 82–91. DOI: 10.2310/6620.2007.06034. DOI: https://doi.org/10.2310/6620.2007.06034
Stepanenko VI. [Dermatology, venereology]. K. : KIM. 2012: 904. Ukrainian.
Coenraads PJ. Hand Eczema. New England Journal of Medicine. 2012;367(19):1829–1837. DOI: 10.1056/nejmcp1104084. DOI: https://doi.org/10.1056/NEJMcp1104084
[Eczema - causes of development, principles of treatment]. Blohy BDMU. BDMU. Holovna storinka. Ukrainian. Available online: https://www.bsmu.edu.ua/blog/6896-ekzema-prichini-rozvitku-printsipi-likuvannya
Chopʺyak VV, Kalyuzhna LD, Stepanenka VI. [Atopic dermatitis. Adapted evidence-based clinical practice]. Derzhavnyy ekspertnyy tsentr Ministerstva okhorony zdorovʺya Ukrayiny. 2016: 113. Ukrainian. Available online: https://www.dec.gov.ua/wp-content/uploads/2019/11/2016_670_akn_ad.pdf
Van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen AP, & Arents, BW. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews, 2017 (2). DOI: 10.1002/14651858.CD012119.pub2/full. DOI: https://doi.org/10.1002/14651858.CD012119
[Medicines Control]. Ukrainian. Available online: https://likicontrol.com.ua/.
[State Register of Medicinal Products of Ukraine]. Ukrainian. Available online: http://www.drlz.com.ua.
[ATC classification] Ukrainian. | Dovidnyk likarsʹkykh preparative Compendium. Compendium.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
